Practo is a healthtech startup based in Bengaluru, India, that connects patients with doctors and provides practice management software for healthcare providers.

This Startup Deep Dive explains what Practo does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Practo in Brief

• What it is: Practo is an Indian Doctor discovery and practice software company based in Bengaluru.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• The platform lets patients search for doctors, book appointments and consult online.
• It also offers practice management software for healthcare providers.
• Users can also order medicines and lab tests through the platform.
• Funding: Reported estimates range from about $211M to $391M; reports differ.

Practo Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Practo?

Practo operates in the Doctor discovery and practice software space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Practo.

• The platform lets patients search for doctors, book appointments and consult online.
• It also offers practice management software for healthcare providers.
• Users can also order medicines and lab tests through the platform.

The Origin Story of Practo

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Shashank ND, Abhinav Lal.
• Practo was founded in 2008 by Shashank ND and Abhinav Lal; one source says 2007, so reports differ.
• It started as a B2B product and was reportedly rebranded from Turbodoc to Practo in late 2010.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Doctor discovery and practice software sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 2008: Founded (one source says 2007).
• January 2017: Series D reportedly valued the company at $620 million.
• August 2020: Round reportedly raised at roughly 50% lower valuation, about $300 million.
• Reported: in talks for a $100-125 Mn pre-IPO round of equity and debt, with an IPO now expected in 2027.

Practo Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• Reported: Series D in January 2017 at a $620 million valuation.
• Reported: $32 Mn round in 2020 from Tencent, Peak XV Partners (then Sequoia), Z47 Partners (then Matrix Partners) and Sofina.
• Reported: advanced talks for a pre-IPO round of $100-125 Mn at about $700M post-money, per unnamed sources; the company did not respond to questions.

How Does Practo Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Revenue sources: The exact revenue mix of Practo is not disclosed in public sources reviewed.
• What to look for: Recurring contracts, repeat customers, gross margin trend and payback on customer acquisition.

The Numbers: Practo Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Audited revenue, profit and loss figures for Practo were not available in the public sources reviewed.
• Readers can check the company’s filings with the Registrar of Companies for the latest financial statements.

Market Opportunity for Practo

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• Company-stated figures vary by source, with claims of over one lakh doctors and 70,000 partner clinics and hospitals on the platform.

Technology and Product at Practo

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• Core capability: Public detail on Practo’s technology stack is limited beyond company-stated descriptions.
• Assessment lens: clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

Team and Culture at Practo

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Shashank ND is co-founder and CEO; Abhinav Lal is co-founder and Chief Product Officer.
• Srijesh Kumar was appointed global CPTO ahead of the planned IPO.

Practo Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

• Direct competitors of Practo vary by product line; a verified rival comparison was not available from public sources.
• What to compare: Product readiness, pricing, customer base, funding runway and regulatory standing.

Risks and Challenges for Practo

• Valuation fell roughly 50% between the 2017 and 2020 rounds, reflecting past down-round pressure.
• Funding totals and the planned $700M valuation rest on unnamed sources and conflicting estimates.
• The planned IPO has been pushed to an expected 2027 listing, so timing remains uncertain.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Practo Growth Outlook: What to Watch

• Reported: the company is expected to go public in 2027 after a pre-IPO round.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Practo can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Practo Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Practo

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Practo.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Practo

Studying a company in the Doctor discovery and practice software space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Practo.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Practo as a Startup

• Customer clarity: Can Practo name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Practo is part of India’s growing Doctor discovery and practice software ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Practo FAQs: Frequently Asked Questions

What is Practo?

Practo is a healthtech startup based in Bengaluru, India, that connects patients with doctors and provides practice management software for healthcare providers. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Practo?

Practo was founded by Shashank ND, Abhinav Lal, and the company reports a founding year of 2008.

How much funding has Practo raised?

Reported estimates range from about $211M to $391M; reports differ. Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Practo make money?

Practo earns revenue from its Doctor discovery and practice software products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Practo?

Competitors of Practo depend on the specific product line. A verified comparison was not available, so see the evaluation checklist above.

What are the main risks for Practo?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Pramatra Space — Pramatra Space raises pre-seed for quantum-secure satellites | SpectraGaze Systems — SpectraGaze raises Rs 3.7 Cr seed to cut detector imports. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.